Skip to content
Baret News – Lifestyle
Author:
Betterment LLC
Genprex Signs Sponsored Research Agreement to Study Biomarkers that May Predict Patient Response to Reqorsa® Gene Therapy
April 21, 2026
Genprex Collaborators Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2026 AACR Annual Meeting
April 20, 2026
Betterment Extends Solo 401(k) Offering to National Wealth Management Partners
April 8, 2026
Betterment at Work Strengthens 401(k) Offering with Renewed Compliance Guarantee and Enhanced Platform Features
March 26, 2026
Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2026 AACR Annual Meeting
March 18, 2026
Genprex to Participate at BIO Europe Spring 2026
March 10, 2026
Betterment Launches AI-Enabled Account Recommender, Advancing Enterprise AI Strategy
March 9, 2026
←
Previous Page
1
2